Akèy › Histiyositoz selil Langerhans › New York
Etid klinik pou Histiyositoz selil Langerhans nan New York
3 etid pou Histiyositoz selil Langerhans ap chèche patisipan nan sit nan New York.
Vil nan New York
Tèks ofisyèl etid la (Anglè)
A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis
- Albany Medical Center, Albany
- Maimonides Medical Center, Brooklyn
- The Steven and Alexandra Cohen Children's Medical Center of New York, New Hyde Park
- ak 7 plis
Ap rekriteFaz 2
180 Days – 22 Years · Tout sèks · Mizajou Oct 2, 2026 · NCT05828069Registry for Patients With Erdheim-Chester Disease and Other Histiocytoses
- Memorial Sloan Kettering Cancer Center, New York
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Jan 8, 2026 · NCT03329274Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histiocytic Disorders
- Memorial Sloan Kettering Cancer Center, New York
Ap rekriteFaz 2
Tout laj · Tout sèks · Mizajou Sep 18, 2025 · NCT04079179Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.